Pazopanib
Active substance: pazopanib
TABLET, FILM COATED · PAZOPANIB HYDROCHLORIDE 200 mg/1
United StatesActive
Marketing holder: SUN PHARMACEUTICAL INDUSTRIES, INC.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PAZOPANIB HYDROCHLORIDE · 200 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-f783-703a-ad7f-9f0ab97d11a5,01a1208d-1664-7aea-98ee-0908c355b8f7,01a1208d-bb73-7cfa-850e-ab3180bd8d3a,01a1208f-8d26-77b2-b841-ffe05e5651fe,01a12091-147a-7866-827b-9e8afb1dc5ad;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63304-116
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 63304-116 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63304-116 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63304-116 · Verified 2026-10-09 · open in source